Login

MINJUVI 200 mg powder for concentrate for solution for infusion

*
Pharmacy Only: Prescription

  • Company:

    Incyte Biosciences UK Ltd

  • Status:

    No Recent Update

  • Legal Category:

    Product subject to restricted prescription (C)

  • Active Ingredient(s):

    Tafasitamab

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

Updated on 19 July 2023

File name

ie-pl.pdf

Reasons for updating

  • New PIL for new product

Updated on 19 July 2023

File name

ie-spc (1).pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to restricted prescription (C)

Updated on 31 January 2023

File name

MINJUVI-ie-spc-ATC code.pdf

Reasons for updating

  • Document format updated

Legal category:Product subject to restricted prescription (C)

Free text change information supplied by the pharmaceutical company

Document format updated

Updated on 03 May 2022

File name

MINJUVI-ie-pl-ATC code.pdf

Reasons for updating

  • New PIL for new product

Updated on 03 May 2022

File name

MINJUVI-ie-spc-ATC code.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to restricted prescription (C)